LENZ Therapeutics, Inc.
4.90%
1,400,220
1815776
52635N103
Aug 17, 2025
Aug 20, 2025, 05:13 PM
Reporting Persons (9)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | Partnership | 4.90% | 1,400,220 | 1,400,220 | 0 |
| Versant Ventures VI GP, L.P. | Partnership | 4.90% | 1,400,220 | 0 | 1,400,220 |
| Versant Ventures VI GP-GP, LLC | Other | 4.90% | 1,400,220 | 0 | 1,400,220 |
| Versant Ventures VII GP-GP, LLC | Other | 3.60% | 1,033,412 | 0 | 1,033,412 |
| Versant Venture Capital VII, L.P. | Partnership | 3.60% | 1,033,412 | 1,033,412 | 0 |
| Versant Ventures VII GP, L.P. | Partnership | 3.60% | 1,033,412 | 0 | 1,033,412 |
| Versant Vantage II, L.P. | Partnership | 3.00% | 842,162 | 842,162 | 0 |
| Versant Vantage II GP, L.P. | Partnership | 3.00% | 842,162 | 0 | 842,162 |
| Versant Vantage II GP-GP, LLC | Other | 3.00% | 842,162 | 0 | 842,162 |
Disclosure Items (2)
Common Stock, par value $0.00001 per share
LENZ Therapeutics, Inc.
201 Lomas Santa Fe Dr., Solana Beach, CA, 92075
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
On August 15, 2025, Versant VI sold 145,051 shares of Common Stock at a price per share of $39.500 for aggregate proceeds of approximately $5,729,514.50. On August 15, 2025, Versant VII sold 69,949 shares of Common Stock at a price per share of $39.500 for aggregate proceeds of approximately $2,762,985.50. On August 18, 2025, Versant VI sold 30,628 shares of Common Stock at a weighted average price per share of $38.5611 for aggregate proceeds of approximately $1,181,049.37. On August 18, 2025, Versant VII sold 15,085 shares of Common Stock at a weighted average price per share of $38.5611 for aggregate proceeds of approximately $581,694.19.